Further, we determined whether treatment of HCC cell lines with a DNA methylation inhibitor, 5-aza-2′-deoxycytidine (5-Aza-CdR), could then restore or increase expression of the SFRP3 mRNA. Here, FRZB is linked to hepatocellular carcinoma.